Container with pillsThe overall goal of the Cancer Therapeutics Program (CTP) is to promote interactions along the continuum of basic, preclinical, and clinical research, to develop innovative approaches to drug treatment of solid tumors and hematologic malignancies.

Specifically, the CTP aims to:

  1. identify new anticancer agents;
  2. understand the mechanism(s) of action of new and existing anticancer drugs; and
  3. optimize schedules and doses of antineoplastic drugs.

Read more about the Cancer Therapeutics Program

See Program Members


Research Themes:

Chemical Diversity

Synthesis of chemicals or moieties that have potential anti-cancer properties

Molecular Targets

Inhibition of key cancer cell pathways as a therapeutic approach

Pharmacokinetics and Pharmacodynamics

Studies of drug uptake and metabolism, dosing, biochemical and physiological effects, and mechanisms of action

Clinical Trials

Design and performance of Phase I, Phase I/II, and Phase II studies of anti-cancer therapeutics